Sector
1090 stories · page 43 of 55
Investors are getting excited about next generation psychedelics that aim to deliver better benefits as medications for big population groups, with full patent protection
The NeuroCatch Platform is a 6-minute brain function assessment system licensed by Health Canada as a Class II medical device
The firm established direct billing practices with Medavie Blue Cross that will cover 100% of the costs of ketamine treatments at Braxia’s Canadian Rapid Treatment Centre of Excellence
Tabula Rasa will provide call center services for Empower's diagnostic laboratory Kai Care's COVID-19 and Influenza A/B at-home salvia test kit
Levitee Labs was born out of an idea to transform the inefficiencies people suffering from mental health disorders, addiction, and pain management issues, tragically experience every day
Archer, who also holds the appointment of interim COO managing the day-to-day operations, succeeds Adam Cegielski
The platform delivers a game-like environment with various skill settings to help improve skills such as hand-eye coordination and reaction time
Deffett, who is also vice president of capital markets, will retain both positions as the company continues to consolidate medical clinics in an effort to become a North American leader in mental health treatments
Bernell will continue to be the authorized distributor for Binovi Touch in the United States, as well as the exclusive North America distributor of Binovi Kit, but will also be the exclusive distributor for the recently acquired Computer Ai
Braxia said it hopes to develop a “new generation” of independent physicians, psychologists and psychotherapists that are interested in using psilocybin to treat depression
CEO Joshua Bartch said the upcoming trial is aimed at achieving safer and more accurate psychedelic-led psychotherapy results in a supervised setting
Pathway’s Medical Cannabis Management System will be introduced first to more than 250 pharmacies in Ontario under the PharmaChoice, PharmaChoix, and Rx HealthMed banners
The online version emulates several of the featured protocols available within the physical Binovi Touch hardware, designed to improve vision and cognitive performance among athletes, organizers, coaches, and umpires
Braxia’s study will look at the use, safety and efficacy of repeated doses of intravenous ketamine in patients who suffer from bipolar depression
Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance
The company said trading in its shares on the TSX Venture Exchange is expected to kick off at market open on Thursday, June 17, 2021
The program’s vision training doctor Anne Hanna said that the technology is “excellent for peripheral vision, saccadic eye movements, fine motor, and cognition"
Its CEO Roger McIntyre and medical director Joshua Rosenblat led a team of experts to develop the International Expert Opinion and Implementation Guidance for the clinical use of rapid-acting ketamine and esketamine for treatment-resistant
There has been a sizable increase in psychedelic companies flocking to stock markets to raise capital in the interest of developing their products and MagicMed was one looking to pursue that path
Binovi Touch Elite measures and trains key vision skills, such as reaction time, hand-eye coordination and peripheral vision, that play a key role in sports performance
